1. Home
  2. GKOS vs EPRT Comparison

GKOS vs EPRT Comparison

Compare GKOS & EPRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • EPRT
  • Stock Information
  • Founded
  • GKOS 1998
  • EPRT 2016
  • Country
  • GKOS United States
  • EPRT United States
  • Employees
  • GKOS N/A
  • EPRT N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • EPRT Real Estate Investment Trusts
  • Sector
  • GKOS Health Care
  • EPRT Real Estate
  • Exchange
  • GKOS Nasdaq
  • EPRT Nasdaq
  • Market Cap
  • GKOS 5.8B
  • EPRT 6.2B
  • IPO Year
  • GKOS 2015
  • EPRT 2018
  • Fundamental
  • Price
  • GKOS $89.83
  • EPRT $30.44
  • Analyst Decision
  • GKOS Strong Buy
  • EPRT Buy
  • Analyst Count
  • GKOS 12
  • EPRT 13
  • Target Price
  • GKOS $131.17
  • EPRT $34.98
  • AVG Volume (30 Days)
  • GKOS 1.2M
  • EPRT 1.6M
  • Earning Date
  • GKOS 07-30-2025
  • EPRT 07-23-2025
  • Dividend Yield
  • GKOS N/A
  • EPRT 3.94%
  • EPS Growth
  • GKOS N/A
  • EPRT 1.76
  • EPS
  • GKOS N/A
  • EPRT 1.19
  • Revenue
  • GKOS $432,953,000.00
  • EPRT $503,256,000.00
  • Revenue This Year
  • GKOS $27.88
  • EPRT $22.35
  • Revenue Next Year
  • GKOS $27.76
  • EPRT $16.78
  • P/E Ratio
  • GKOS N/A
  • EPRT $25.58
  • Revenue Growth
  • GKOS 26.70
  • EPRT 25.14
  • 52 Week Low
  • GKOS $77.10
  • EPRT $27.44
  • 52 Week High
  • GKOS $163.71
  • EPRT $34.88
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 43.89
  • EPRT 46.12
  • Support Level
  • GKOS $88.94
  • EPRT $29.76
  • Resistance Level
  • GKOS $92.70
  • EPRT $30.58
  • Average True Range (ATR)
  • GKOS 3.82
  • EPRT 0.56
  • MACD
  • GKOS 0.38
  • EPRT 0.04
  • Stochastic Oscillator
  • GKOS 46.71
  • EPRT 41.09

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About EPRT Essential Properties Realty Trust Inc.

Essential Properties Realty Trust Inc is a real estate investment trust. It is an internally managed real estate company acquires, owns and manages single-tenant properties that are net leased on a long-term basis to middle-market companies operating service-oriented or experience-based businesses. The Company generally invests in and leases freestanding, single-tenant commercial real estate facilities where a tenant services its customers and conducts activities that are essential to the generation of the tenant's sales and profits.

Share on Social Networks: